MASI:NASDAQMasimo Corporation Analysis
Data as of 2026-05-26 - not real-time
$178.67
Latest Price
4/10Risk
Risk Level: Medium
Executive Summary
Masimo’s shares are trading at $178.67, tightly hugging the 20‑day SMA (≈$178.54) and the 50‑day SMA, with a bullish trend direction but a bearish MACD histogram signaling short‑term downside pressure. The RSI sits at 60, indicating modest momentum, while volatility is low (≈1.3% over 30 days) and beta is subdued (Fundamentally, the company posts solid profitability (gross margin 61.6%, operating margin 23.6%) and a strong ROE of ~25%, yet valuation metrics are stretched: trailing P/E 44× versus an industry average of 27×, and a DCF fair value of $110 versus the current price, flagging the stock as overvalued. The “Extreme Greed” sentiment in the Fear & Greed Index further hints at potential complacency among investors.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 7/10
Key Factors
- Price exceeds DCF fair value, indicating limited upside
- Bearish MACD histogram and proximity to resistance level
- High trailing P/E relative to industry peers
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Strong operating margins and cash flow generation
- Continued revenue growth (~8.5% YoY) supporting earnings expansion
- Valuation gap may narrow as market re‑prices growth prospects
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Robust ROE and expanding product portfolio in patient monitoring
- Low beta and low volatility provide defensive characteristics
- Long‑term demand for advanced medical‑device solutions
Key Metrics & Analysis
Financial Health
Revenue Growth8.50%
Profit Margin4.90%
P/E Ratio44.2
ROE24.99%
ROA10.20%
Debt/Equity61.59
P/B Ratio11.9
Op. Cash Flow$232.0M
Free Cash Flow$327.9M
Industry P/E27.4
Technical Analysis
TrendBullish
RSI60.1
Support$178.17
Resistance$178.94
MA 20$178.54
MA 50$178.23
MA 200$154.42
MACDBearish
VolumeStable
Fear & Greed Index91.05
Valuation
Fair Value$110.11
Target Price$180.00
Upside/Downside0.74%
GradeOvervalued
TypeGrowth
Risk Assessment
Beta0.44
Volatility1.30%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.